Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/17/2025 | $15.00 → $12.00 | Sell → Neutral | UBS |
| 3/4/2025 | $26.00 → $16.00 | Buy → Hold | TD Cowen |
| 2/4/2025 | $20.50 → $15.00 | Neutral → Sell | UBS |
| 11/11/2024 | $27.00 → $26.00 | Buy | TD Cowen |
| 10/17/2024 | $22.00 → $27.00 | Buy | TD Cowen |
| 8/12/2024 | $20.00 → $18.00 | Buy | TD Cowen |
| 8/18/2022 | $14.00 → $23.00 | Neutral → Buy | Goldman |
| 2/28/2022 | $23.00 → $20.00 | Outperform | Cowen |
4 - Calumet, Inc. /DE (0002013745) (Issuer)
4 - Calumet, Inc. /DE (0002013745) (Issuer)
4 - Calumet, Inc. /DE (0002013745) (Issuer)
INDIANAPOLIS, Aug. 3, 2022 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) ("Calumet", "the Partnership", "we", "us", "our") announced today the appointment of Karen Twitchell and John (Jack) Boss to the Board of Directors effective August 2, 2022. Concurrently, Calumet announced that Robert (Bob) Funk has elected to retire from the Board of Directors. "On behalf of everyone at Calumet, I'd like to thank Bob for his many years of service and significant contributions to the Partnership. We'll particularly miss his operational expertise, wisdom and commitment to the success of Calumet," said Steve Mawer, Executive Chairman. "When Bob notified us of his intent to reti
Fourth quarter 2024 net loss of $40.7 million, or basic loss per common share of $0.47 per shareFourth quarter 2024 Adjusted EBITDA of $56.6 millionAnnounces sale of Royal Purple® industrial business for $110 millionMontana Renewables received initial funds from U.S. Department of Energy ("DOE") loan in February 2025Specialties business posts record sales volume and cost improvement in 2024INDIANAPOLIS, Feb. 28, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) today reported results of Calumet, Inc. (the "Company," "Calumet," "we," "our" or "us") for the fourth quarter ended December 31, 2024, as follows: Three Months Ended December 31, Year Ended December 31, 2024 2023 2024 2023 (Dollars
INDIANAPOLIS, Feb. 14, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to report results for the Fourth Quarter and Fiscal Year 2024 on February 28, 2025. A conference call to discuss the financial and operational results is scheduled for February 28th at 9:00 AM ET. Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides; parties interested in listening to the webcast may follow the link which will be made available at http://calumetspecialty.investorroom.com/events. For those participants w
INDIANAPOLIS, Jan. 10, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to hold an analysts call on January 13, 2025, at 9:00 a.m. ET to discuss the closing of its $1.44 billion guaranteed loan with the U.S. Department of Energy Loan Programs Office. Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides; parties interested in listening to the webcast may follow the link which will be made available at http://calumetspecialty.investorroom.com/events. For those participants wishing to dial i
4 - Calumet, Inc. /DE (0002013745) (Issuer)
4 - Calumet Specialty Products Partners, L.P. (0001340122) (Issuer)
INDIANAPOLIS, April 1, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us") has successfully closed its previously announced sale of assets related to the industrial portion of its Royal Purple® business, for $110 million in cash to a wholly owned subsidiary of Lubrication Engineers, Inc., a portfolio company of Aurora Capital Partners. The assets sold related to Royal Purple's high performance synthetic industrial product line including industrial gear lubricants, bio-environmental lubricants, stationary natural gas engine oils, hydraulic lubricants, and compressor oils, along with an exclusive license of the brand for industrial applications.
INDIANAPOLIS, March 17, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we") today announced that Julio Quintana and Karen Narwold have been selected as nominees for election to the Board of Directors of Calumet (the "Board") at the Company's 2025 Annual Meeting of Stockholders (the "Annual Meeting"). After successfully guiding the Company through the transition from a master limited partnership (MLP) to a C-Corporation, Jim Carter and Dan Sheets have informed the Board of their decision not to seek re-election and to retire at the end of their terms following the Annual Meeting. In connection with the Company's ongoing governance transition process, Calumet's
INDIANAPOLIS, March 4, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) ("Calumet") announced today plans to attend the Wolfe Research Refining Conference Thursday, March 6, 2025, in New York. Calumet will be holding one-on-one investor meetings throughout the day at the conference. About Calumet Calumet, Inc. (NASDAQ:CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. Calumet is headquartered in Indianapolis, Indiana and operates twelve facilities throughout North America. View original content:https://www.prnewswire.com/news-releases/calumet-to-
144 - Calumet, Inc. /DE (0002013745) (Subject)
SCHEDULE 13G - Calumet, Inc. /DE (0002013745) (Subject)
8-K - Calumet, Inc. /DE (0002013745) (Filer)
SC 13G/A - Calumet Specialty Products Partners, L.P. (0001340122) (Subject)
SC 13G/A - Calumet Specialty Products Partners, L.P. (0001340122) (Subject)
SC 13G/A - Calumet Specialty Products Partners, L.P. (0001340122) (Subject)
UBS upgraded Calumet Specialty Products from Sell to Neutral and set a new price target of $12.00 from $15.00 previously
TD Cowen downgraded Calumet Specialty Products from Buy to Hold and set a new price target of $16.00 from $26.00 previously
UBS downgraded Calumet Specialty Products from Neutral to Sell and set a new price target of $15.00 from $20.50 previously